⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
El Meijer LPGA Classic for Simply Give 2026 regresa con las experiencias familiares favoritas de los fanáticos USA - español USA - English
prnewswire.com
V
MSFT
GOOG
AMZN
M
TGT
WMT
KR
COST
PG
JNJ
KO
PEP
MCD
SBUX
DIS
CMCSA
NFLX
AMAT
NVDA
INTC
AMD
QCOM
MU
TXN
ADI
NXPI
MRVL
SNPS
CDNS
ASML
LRCX
KLAC
AMGN
GILD
BMY
PFE
MRK
ABBV
LLY
JPM
BAC
WFC
C
GS
MS
AXP
IBM
ORCL
CRM
CSCO
ACN
ADP
NOW
ADBE
EA
TTWO
CRSP
REGN
VRTX
BIIB
ALGN
EXPE
BKNG
MAR
HPE
DELL
HPQ
AVGO
ADSK
PAYX
FISV
PYPL
MELI
EBAY
BABA
JD
PDD
NIO
XPEV
LI
TSLA
RIVN
LCID
GM
F
STLA
TM
HMC
VWAGY
BBD
AAPL
META
SNAP
PINS
The Shift from Analytics to Intelligence Takes Center Stage at Seeq Conneqt North America 2026
prnewswire.com
IP
PBF
INTC
LLY
D
Lilly to spotlight growing hematology portfolio at 2026 European Hematology Association (EHA) Annual Meeting
prnewswire.com
LLY
EfficientCME Wins Top Poster Award at the Obesity Medicine Association's 2026 Annual Conference
globenewswire.com
LLY
KFS
Augustine Therapeutics to Present Late-Breaking Poster at the American Diabetes Association’s 86th Scientific Sessions
globenewswire.com
LLY
DigiCert Research Reveals Major Certificate Visibility Blind Spot for Enterprises
globenewswire.com
MSFT
GOOG
AMZN
IBM
ORCL
CSCO
DELL
HPQ
INTC
QCOM
NVDA
AMD
AVGO
MU
AMAT
LRCX
KLAC
ADI
TXN
NXPI
MRVL
SNPS
CDNS
ADSK
CRM
ACN
INFY
SAP
PANW
CRWD
OKTA
FTNT
DDOG
NOW
MCHP
ON
LULU
BBY
COST
HD
LOW
TJX
MDT
AMGN
GILD
BMY
PFE
MRK
JNJ
ABBV
LLY
BIIB
REGN
VRTX
AZN
SNOW
SMCI
PLTR
AI
GOOGL
Lilly’s Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode
globenewswire.com
LLY
NTHI
OLMA
PFE
Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas
prnewswire.com
LLY
Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
prnewswire.com
LLY
Kelonia Therapeutics Presents Updated First-in-Human Data from Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
businesswire.com
LLY